Sun X J, Zhang G M, Zheng H, Miao N, Wang H Q, Yin Z D, Wang F Z
National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Apr 6;53(4):382-387. doi: 10.3760/cma.j.issn.0253-9624.2019.04.010.
To analyze the changing epidemiological characteristics of hepatitis E cases in China, in order to promote in preventing and controlling hepatitis E. Data of hepatitis E and outbreaks reported through national notifiable diseases reporting system were analyzed from 2004 to 2017, but data of Hongkong, Macau and Taiwan were not included. Data of hepatitis E were divided into three phases as 2004-2007, 2008-2011 and 2012-2017, representing eight years before, four years before and years after the postmarketing of hepatitis E vaccine. Linear regression was used for analyzing the trend of hepatitis E, improved muster method was used for analyzing the seasonal intensity. From 2004 to 2017, 329 519 hepatitis E cases were reported and the annual incidence were increasing from 1.27/100 000 to 2.10/100 000 (6.87, 0.001). The concentrations of hepatitis E during 2004-2007, 2008-2011 and 2012-2017 were 17.43, 16.06, 11.17, respectively, with low seasonal intensity. Number of cases reported by Jiangsu, Guangdong and Zhejiang accounted for 31.54% of national cases. The incidence were lower in central (1.45/100 000) and western (1.11/100 000) region than that in eastern region (2.67/100 000), but were increasing continuously. There was an increasing trend of incidence with growing ages (7.85, 0.001). The incidence was higher than 2/100 000 among cases aged ≥40, and was the highest (5.22/100 000) in the age group of 65-69 years old. Farmers, retired persons, houseworkers and unemployees accounted for 67.46% of total cases. A total of 7 outbreaks were reported, among which 3 were in nursing homes. The incidence of hepatitis E in central and western regions were increasing continuously and the surveillance should be strengthened. There was higher risk among middle-aged population, farmers and nursing homes, so strategy for immunization among those population was in great need.
为分析中国戊型肝炎病例的流行病学特征变化,以促进戊型肝炎的防控工作。对2004年至2017年通过国家法定传染病报告系统报告的戊型肝炎及疫情数据进行分析,不包括香港、澳门和台湾的数据。戊型肝炎数据分为2004 - 2007年、2008 - 2011年和2012 - 2017年三个阶段,分别代表戊型肝炎疫苗上市前8年、前4年和上市后若干年。采用线性回归分析戊型肝炎发病趋势,用改进的集中度法分析季节强度。2004年至2017年,共报告戊型肝炎病例329519例,年发病率从1.27/10万上升至2.10/10万(χ² = 6.87,P = 0.001)。2004 - 2007年、2008 - 2011年和2012 - 2017年戊型肝炎集中度分别为17.43、16.06、11.17,季节强度较低。江苏、广东和浙江报告的病例数占全国病例数的31.54%。中部地区(1.45/10万)和西部地区(1.11/10万)发病率低于东部地区(2.67/10万),但呈持续上升趋势。发病率随年龄增长呈上升趋势(χ² = 7.85,P = 0.001)。年龄≥40岁人群发病率高于2/10万,65 - 69岁年龄组发病率最高(5.22/10万)。农民、退休人员、家务劳动者和无业人员占总病例数的67.46%。共报告7起疫情,其中3起发生在养老院。中西部地区戊型肝炎发病率持续上升,应加强监测。中年人群、农民和养老院人群风险较高,急需针对这些人群的免疫策略。